Hybrigenics SA (ALHYG) - Financial and Strategic SWOT Analysis Review

Date: May 23, 2018
Pages: 34
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H8B7A593D42EN
Leaflet:

Download PDF Leaflet

Hybrigenics SA (ALHYG) - Financial and Strategic SWOT Analysis Review
Hybrigenics SA (ALHYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Hybrigenics SA (Hybrigenics) offers research and development of new targets and therapies against proliferative cancerous or non-cancerous diseases. Its lead product candidate Inecalcitol, is a vitamin D receptor agonist being assessed for various cancer indications including prostate cancer, chronic lymphocytic leukaemia and moderate to severe psoriasis. Hybrigenics research program investigates the action of deubiquitinating enzymes (DUB) in the recycling of onco-proteins and the utility of proprietary patented DUB inhibitors against various cancer indications. The company has expertise in the field of DUBs, which it applies to the discovery and development of new treatments. It also markets specialized scientific services that aid in validating and inhibiting protein interactions in animal, plant or microbiological cells. Hybrigenics is headquartered in Paris, France.

Hybrigenics SA Key Recent Developments

Apr 26,2018: Hybrigenics Announces Its Full Year 2017 Results
Apr 28,2017: Hybrigenics fuLL year 2016 resuLts

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

NOTE: Out of security concerns GlobalData requires using corporate email address.
SECTION 1 - ABOUT THE COMPANY

Hybrigenics SA - Key Facts
Hybrigenics SA - Key Employees
Hybrigenics SA - Key Employee Biographies
Hybrigenics SA - Major Products and Services
Hybrigenics SA - History
Hybrigenics SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Hybrigenics SA - Business Description
Hybrigenics SA - Corporate Strategy
Hybrigenics SA - SWOT Analysis
SWOT Analysis - Overview
Hybrigenics SA - Strengths
Hybrigenics SA - Weaknesses
Hybrigenics SA - Opportunities
Hybrigenics SA - Threats
Hybrigenics SA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Hybrigenics SA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 26, 2018: Hybrigenics Announces Its Full Year 2017 Results
Apr 28, 2017: Hybrigenics fuLL year 2016 resuLts

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Hybrigenics SA, Key Facts
Hybrigenics SA, Key Employees
Hybrigenics SA, Key Employee Biographies
Hybrigenics SA, Major Products and Services
Hybrigenics SA, History
Hybrigenics SA, Subsidiaries
Hybrigenics SA, Key Competitors
Hybrigenics SA, Ratios based on current share price
Hybrigenics SA, Annual Ratios
Hybrigenics SA, Annual Ratios (Cont.1)
Hybrigenics SA, Interim Ratios
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Hybrigenics SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Hybrigenics SA, Performance Chart (2013 - 2017)
Hybrigenics SA, Ratio Charts
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Hybrigenics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Vaxon Biotech
Transgene SA
Quantum Genomics SA
Qiagen Marseille SA
Innate Pharma SA
Erytech Pharma SA
Bioquanta SA
Skip to top


Ask Your Question

Hybrigenics SA (ALHYG) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: